Innovation in digital health tools, including mobile health apps and wearable sensors, bring new approaches to the management of health conditions. Digital therapeutics to treat human disease are being approved by regulatory agencies around the world and routes to reimbursement are being established as developers generate and submit high-quality data on effectiveness to payers and employers. Further, new digital biomarkers are being created using consumer wearables, with the intent to track elements of patient health remotely. As these digital tools begin to have a fundamental impact on patient care and influence clinical trial design, it is important to assess the innovation and evidence they contribute as well as the barriers to and facilitators of their adoption.
top of page
Search
bottom of page
Comments